# Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

> **NCT02740868** · PHASE2 · RECRUITING · sponsor: **The Hospital for Sick Children** · enrollment: 30 (estimated)

## Conditions studied

- Cystic Fibrosis
- Asthma

## Interventions

- **DRUG:** Xenon-129 and Perfluoropropane (19F)
- **DEVICE:** Magnetic Resonance Imaging
- **DEVICE:** Lung Clearance Index

## Key facts

- **NCT ID:** NCT02740868
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-08
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02740868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02740868, "Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02740868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*